Skip to content

Viral suppression in Uganda improved by more viral load tests, done faster

Slide from Dr Vivek Jain's presentation to IAS 2021.

Weight gain after changing treatment more likely when switching from efavirenz or old-style tenofovir

Blue_Deep/Shutterstock.com

Near point-of-care viral load testing enables quick clinical action for people with high viral load

Laboratory technician at the Lighthouse Trust, Lilongwe, Malawi

Top 5 stories on HIV treatment and care in Africa from CROI 2021

Professor Nicholas Paton (bottom, left) presenting the study on second-line treatment to CROI 2021.

Resistance testing does not improve viral suppression after first-line failure in South Africa and Uganda

Dr Mark Siedner (top right) presenting to CROI 2021.

African study confirms dolutegravir for second-line treatment and supports recycling of tenofovir

Professor Nicholas Paton (bottom, left) presenting to CROI 2021.

Near point-of-care viral load tests slash waiting times in seven African countries

Haba Pokpa, MSF Lab Technician in the MSF supported laboratory in Matam health centre, Conakry, Guinea captures results from GeneXpert tests. Image by Albert Masais/MSF.

Genetics may contribute to weight gain after switching from efavirenz to an integrase inhibitor

Image: World Obesity Federation.

Top 5 HIV treatment stories at AIDS 2020

Image: Haitian Global Health Alliance / www.gheskio.org